Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. IBSA Institut Biochimique SA
FDA Inspection
•IBSA Institut Biochimique SA•March 24, 2023

IBSA Institut Biochimique SA – FDA Inspection, Mar 24, 2023

Record Details

This FDA Inspection record concerns IBSA Institut Biochimique SA, with an inspection on March 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
IBSA Institut Biochimique SA
Inspection Date
March 24, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Miguel A. Martinez
  • Teresa I. Navas
View Company Profile

ID · f6ac1d98-bfdc-4d34-9f34-e3f7b77dd3fd

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1201222
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

17
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.194(d)Laboratory equipment calibration records
  4. 21 CFR 211.113(a)Procedures for non-sterile drug products
  5. 21 CFR 211.170(b)Reserve samples identified, representative, stored
  6. 21 CFR 211.170(b)Annual visual exams of drug products
  7. 21 CFR 211.165(a)Testing and release for distribution
  8. 21 CFR 211.166(a)Written program not followed
  9. 21 CFR 211.192Written record of investigation incomplete
  10. 21 CFR 211.110(a)Control procedures to monitor and validate performance

Showing 10 of 17 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of IBSA Institut Biochimique SA

8
DateClassificationOfficeProject area
March 28, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
June 22, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 8, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 30, 2015NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 27, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for IBSA Institut Biochimique SA
  • FDA Inspection 1088003 - 2019-03-28
  • FDA Inspection 1056552 - 2018-06-22
  • FDA Inspection 981959 - 2016-07-08
  • FDA Inspection 938124 - 2015-07-30
  • FDA Inspection 853655 - 2013-09-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore IBSA Institut Biochimique SA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.